Mechanistic investigation of immunosuppression in patients with condyloma acuminata

Shi,Yu-Jie; Yang,Jian; Yang,Wenlin

doi:10.3892/mmr.2013.1511

Mechanistic investigation of immunosuppression in patients with condyloma acuminata

Authors:
- Yu-Jie Shi
- Jian Yang
- Wenlin Yang
View Affiliations

Affiliations: Department of Dermatology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, P.R. China
Published online on: June 6, 2013 https://doi.org/10.3892/mmr.2013.1511
Pages: 480-486

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Condyloma acuminatum (CA) is a common sexually transmitted disease caused by human papillomavirus (HPV) infection. Previous studies have identified that the occurrence, relapse and cancerization of CA is relevant to immune imbalance caused by immune hypofunction or immunoregulatory dysfunction. However, to date, the specific mechanisms accounting for immune imbalance in CA patients have remained elusive. In the present study, changes in the expression levels of myeloid differentiation factor 88 (MyD88) and toll‑like receptors (TLRs) were determined in lesion tissues and peripheral blood samples obtained from CA patients by fluorescence quantitative PCR and western blot analysis. The results indicated that TLRs and MyD88 expression was upregulated in the lesion tissues only. In addition, the expression of forkhead box P3, a characteristic marker of regulatory T cells (Tregs), transforming growth factor‑β1 and interleukin (IL)‑10, inhibitory factors secreted by Tregs and inhibitory costimulatory molecules, cytotoxic T-lymphocyte antigen 4, glucocorticoid-induced TNFR-related protein and programmed cell death protein 1 was observed to be upregulated, indicating that immunosuppression of Tregs was enhanced significantly. However, the expression levels of NKG2D and NKp46, natural killer (NK) cell activation receptors located on the surface of NK cells, decreased markedly indicating that HPV infection inhibits the activation of NK cells. The secretion levels of various cytokines in the peripheral blood of CA patients were detected by enzyme‑linked immunosorbent assay revealing that IL‑2, IL‑12 and interferon‑γ levels were markedly lower than that of healthy subjects. By contrast, the expression levels of tumor necrosis factor‑α, IL‑4 and IL‑10 were markedly increased in CA samples compared with the control, with the exception of IL‑6. Taken together, these results are consistent with the hypothesis of immunosuppression in CA patients. Increased expression of MyD88 and TLRs is likely to enhance immunosuppression of Tregs, leading to the imbalance of Th1/Th2, cytotoxic T cell type 1 (Tc1)/Tc2 cells and secreted cytokines.

View Figures

View References

1	O’Mahony C: Genital warts: current and future management options. Am J Clin Dermatol. 6:239–243. 2005.PubMed/NCBI
2	McMurray HR, Nguyen D, Westbrook TF and McAnce DJ: Biology of human papillomaviruses. Int J Exp Pathol. 82:15–33. 2001. View Article : Google Scholar
3	Partridge JM and Koutsky LA: Genital human papillomavirus infection in men. Lancet Infect Dis. 6:21–31. 2006. View Article : Google Scholar : PubMed/NCBI
4	Akira S and Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar
5	Xagorari A and Chlichlia K: Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol J. 2:49–59. 2008.PubMed/NCBI
6	Sin JI: MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model. Vaccine. 29:4125–4131. 2011. View Article : Google Scholar : PubMed/NCBI
7	Ahmed AM, Madkan V and Tyring SK: Human papillomaviruses and genital disease. Dermatol Clin. 24:157–165. 2006. View Article : Google Scholar : PubMed/NCBI
8	Narayan S, Choyce A, Linedale R, et al: Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4⁺CD25⁺ T cells. Eur J Immunol. 39:481–490. 2009. View Article : Google Scholar : PubMed/NCBI
9	Liu XS, Leerberg J, MacDonald K, Leggatt GR and Frazer IH: IFN-gamma promotes generation of IL-10 secreting CD4⁺T cells that suppress generation of CD8 responses in an antigen-experienced host. J Immunol. 183:51–58. 2009.PubMed/NCBI
10	Cao Y, Zhao J, Lei Z, et al: Local accumulation of FOXP3⁺regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata. J Immunol. 180:7681–7686. 2008.PubMed/NCBI
11	Del Mistro A, Koss LG, Braunstein J, Bennett B, Saccomano G and Simons KM: Condylomata acuminata of the urinary bladder. Natural history, viral typing and DNA content. Am J Surg Pathol. 12:205–215. 1988.PubMed/NCBI
12	Daud II, Scott ME, Ma Y, Shiboski S, Farhat S and Moscicki AB: Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer. 128:879–886. 2011. View Article : Google Scholar : PubMed/NCBI
13	Shi YJ, Xiong F, Yang J, et al: The expression and significance of MyD88 in condyloma acuminatum. Zhong Guo PiFu Xing Bing Xue Za Zhi. 24:626–628. 2010.(In Chinese).
14	Xu Y, Zhu KJ, Zhu N, Jiang DH, Chen XZ and Cheng H: Expression of Foxp3⁺CD4⁺CD25⁺ regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of patients with condyloma acuminatum. Clin Exp Dermatol. 34:229–235. 2009.
15	Villa LL, Costa RL, Petta CA, et al: High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer. 95:1459–1466. 2006.PubMed/NCBI
16	Ku JK, Kwon HJ, Kim MY, et al: Expression of Toll-like receptors in verruca and molluscum contagiosum. J Korean Med Sci. 23:307–314. 2008. View Article : Google Scholar : PubMed/NCBI
17	Yang R, Murillo FM, Cui H, et al: Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. J Virol. 78:11152–11160. 2004. View Article : Google Scholar : PubMed/NCBI
18	Ochs HD, Gambineri E and Torgerson TR: IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res. 38:112–121. 2007. View Article : Google Scholar : PubMed/NCBI
19	van Maren WW, Jacobs JF, de Vries IJ, Nierkens S and Adema GJ: Toll-like receptor signalling on Tregs: to suppress or not to suppress? Immunology. 124:445–452. 2008.PubMed/NCBI
20	Caramalho I, Lopes-Carvalho T, Ostler D, et al: Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med. 197:403–411. 2003. View Article : Google Scholar : PubMed/NCBI
21	Khattri R, Cox T, Yasayko SA and Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 4:337–342. 2003.PubMed/NCBI
22	Hori S, Nomura T and Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057–1061. 2003. View Article : Google Scholar : PubMed/NCBI
23	Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P and Yamaguchi T: Regulatory T cells: how do they suppress immune responses? Int Immunol. 21:1105–1111. 2009. View Article : Google Scholar : PubMed/NCBI
24	Huber S, Schramm C, Lehr HA, et al: Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4⁺CD25⁺ T cells. J Immunol. 173:6526–6531. 2004. View Article : Google Scholar : PubMed/NCBI
25	Molling JW, de Gruijl TD, Glim J, et al: CD4(⁺)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer. 121:1749–1755. 2007.
26	Sun J, Walsh M, Villarino AV, et al: TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J Immunol. 174:742–751. 2005. View Article : Google Scholar : PubMed/NCBI
27	Kaisho T, Hoshino K, Iwabe T, Takeuchi O, Yasui T and Akira S: Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int Immunol. 14:695–700. 2002. View Article : Google Scholar : PubMed/NCBI
28	Bais AG, Beckmann I, Lindemans J, et al: A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol. 58:1096–1100. 2005. View Article : Google Scholar : PubMed/NCBI